Researcher.Life Logo

Infectious Agents and Cancer : Impact Factor & More

eISSN: 1750-9378pISSN: 1750-9378
JournalOpen Access

Key Metrics

CiteScore
4.5
Impact Factor
< 5
SJR
Q3Oncology
SNIP
0.88
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Infectious Agents and Cancer

Infectious Agents and Cancer Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2490 | USD 2990 | GBP 2190
Publication Time17
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorAfrican Organization for Research and Training on Cancer (AORTIC)
FrequencyContinuous publication
Publication Start Year2006
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 17
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in Infectious Agents and Cancer ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Infectious Agents and Cancer

Absence of chlamydial infection in ocular adnexal MALT lymphoma based on next-generation sequencing.
  • 4 May 2026
  • Infectious agents and cancer
Paired box 1 gene methylation as a promising triage strategy for atypical squamous cells: a retrospective comparison with high-risk HPV testing in cervical cancer screening.
  • 24 Apr 2026
  • Infectious agents and cancer
Penile HPV prevalence among high-risk men in Sri Lanka: baseline insight for HPV prevention strategies in a lower-middle-income country.
  • 23 Apr 2026
  • Infectious agents and cancer
High-risk human papillomavirus genotypes in cervical squamous cell carcinomas diagnosed in Rwanda.
  • 21 Apr 2026
  • Infectious agents and cancer
Global research on the crosstalk between microbiota - intratumoral microorganisms and liver cancer: a visualization analysis.
  • 20 Apr 2026
  • Infectious agents and cancer
Oral microbiome diversity, community- and taxon-level differences by oral human papillomavirus (HPV) and race/ethnicity.
  • 14 Apr 2026
  • Infectious agents and cancer
Absence of chlamydial infection in ocular adnexal MALT lymphoma based on next-generation sequencing.
  • 4 May 2026
  • Infectious agents and cancer
Paired box 1 gene methylation as a promising triage strategy for atypical squamous cells: a retrospective comparison with high-risk HPV testing in cervical cancer screening.
  • 24 Apr 2026
  • Infectious agents and cancer
Penile HPV prevalence among high-risk men in Sri Lanka: baseline insight for HPV prevention strategies in a lower-middle-income country.
  • 23 Apr 2026
  • Infectious agents and cancer
High-risk human papillomavirus genotypes in cervical squamous cell carcinomas diagnosed in Rwanda.
  • 21 Apr 2026
  • Infectious agents and cancer
Global research on the crosstalk between microbiota - intratumoral microorganisms and liver cancer: a visualization analysis.
  • 20 Apr 2026
  • Infectious agents and cancer
Oral microbiome diversity, community- and taxon-level differences by oral human papillomavirus (HPV) and race/ethnicity.
  • 14 Apr 2026
  • Infectious agents and cancer

FAQs on Infectious Agents and Cancer